These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24505478)

  • 1. High-content, high-throughput screening for the identification of cytotoxic compounds based on cell morphology and cell proliferation markers.
    Martin HL; Adams M; Higgins J; Bond J; Morrison EE; Bell SM; Warriner S; Nelson A; Tomlinson DC
    PLoS One; 2014; 9(2):e88338. PubMed ID: 24505478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image-Based Annotation of Chemogenomic Libraries for Phenotypic Screening.
    Tjaden A; Chaikuad A; Kowarz E; Marschalek R; Knapp S; Schröder M; Müller S
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel high-throughput cellular screening assay for the discovery of HIV-1 integrase inhibitors.
    Van Loock M; Meersseman G; Van Acker K; Van Den Eynde C; Jochmans D; Van Schoubroeck B; Dams G; Heyndrickx L; Clayton RF
    J Virol Methods; 2012 Feb; 179(2):396-401. PubMed ID: 22172974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High throughput screening for small molecule enhancers of the interferon signaling pathway to drive next-generation antiviral drug discovery.
    Patel DA; Patel AC; Nolan WC; Zhang Y; Holtzman MJ
    PLoS One; 2012; 7(5):e36594. PubMed ID: 22574190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High content screening for compounds that induce early stages of human embryonic stem cell differentiation.
    Jee J; Jeon H; Hwang D; Sommer P; Park Z; Cechetto J; Dorval T
    Comb Chem High Throughput Screen; 2012 Sep; 15(8):656-65. PubMed ID: 22364550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. poolHiTS: a shifted transversal design based pooling strategy for high-throughput drug screening.
    Kainkaryam RM; Woolf PJ
    BMC Bioinformatics; 2008 May; 9():256. PubMed ID: 18513431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vivo multiplexed small-molecule screening platform.
    Grüner BM; Schulze CJ; Yang D; Ogasawara D; Dix MM; Rogers ZN; Chuang CH; McFarland CD; Chiou SH; Brown JM; Cravatt BF; Bogyo M; Winslow MM
    Nat Methods; 2016 Oct; 13(10):883-889. PubMed ID: 27617390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screening.
    Moorwood C; Lozynska O; Suri N; Napper AD; Diamond SL; Khurana TS
    PLoS One; 2011; 6(10):e26169. PubMed ID: 22028826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules.
    Fouda A; Tahsini M; Khodayarian F; Al-Nafisah F; Rafei M
    J Vis Exp; 2017 Mar; (121):. PubMed ID: 28362377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic assays for chemical biology and drug discovery.
    Gul S
    Clin Epigenetics; 2017; 9():41. PubMed ID: 28439316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of adiponectin receptor agonist utilizing a fluorescence polarization based high throughput assay.
    Sun Y; Zang Z; Zhong L; Wu M; Su Q; Gao X; Zan W; Lin D; Zhao Y; Zhang Z
    PLoS One; 2013; 8(5):e63354. PubMed ID: 23691032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational methods for the selection of diverse screening compounds.
    Huggins DJ; Venkitaraman AR; Spring DR
    ACS Chem Biol; 2011 Mar; 6(3):208-17. PubMed ID: 21261294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR modeling of imbalanced high-throughput screening data in PubChem.
    Zakharov AV; Peach ML; Sitzmann M; Nicklaus MC
    J Chem Inf Model; 2014 Mar; 54(3):705-12. PubMed ID: 24524735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hit-to-Lead: Hit Validation and Assessment.
    Hevener KE; Pesavento R; Ren J; Lee H; Ratia K; Johnson ME
    Methods Enzymol; 2018; 610():265-309. PubMed ID: 30390802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Combination of Screening and Computational Approaches for the Identification of Novel Compounds That Decrease Mast Cell Degranulation.
    McShane MP; Friedrichson T; Giner A; Meyenhofer F; Barsacchi R; Bickle M; Zerial M
    J Biomol Screen; 2015 Jul; 20(6):720-8. PubMed ID: 25838434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of microscopy and Alamar blue reduction in a larval based assay for schistosome drug screening.
    Mansour NR; Bickle QD
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e795. PubMed ID: 20706580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenotypic screens or one stone to kill two birds: discover the target and its pharmacological regulator].
    Prudent R; Soleilhac E; Barette C; Fauvarque MO; Lafanechère L
    Med Sci (Paris); 2013 Oct; 29(10):897-905. PubMed ID: 24148129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and optimization of a high-throughput screening method utilizing Ancylostoma ceylanicum egg hatching to identify novel anthelmintics.
    Abriola L; Hoyer D; Caffrey CR; Williams DL; Yoshino TP; Vermeire JJ
    PLoS One; 2019; 14(6):e0217019. PubMed ID: 31158236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-content screening of natural products reveals novel nuclear export inhibitors.
    Cautain B; de Pedro N; Murillo Garzón V; Muñoz de Escalona M; González Menéndez V; Tormo JR; Martin J; El Aouad N; Reyes F; Asensio F; Genilloud O; Vicente F; Link W
    J Biomol Screen; 2014 Jan; 19(1):57-65. PubMed ID: 24045581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microscale Adaptation of In Vitro Transcription/Translation for High-Throughput Screening of Natural Product Extract Libraries.
    Lowell AN; Santoro N; Swaney SM; McQuade TJ; Schultz PJ; Larsen MJ; Sherman DH
    Chem Biol Drug Des; 2015 Dec; 86(6):1331-8. PubMed ID: 26147927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.